“Bioneb has the potential to change the future of medicine, others can only dream of “
Nick Havercroft – CEO & Founder Bioneb
Ultrasonic Vibrating Micron Micro Mesh Technology
Bioneb strives to be a leader in the pulmonary delivery of medical formulations.
Patent approved FDA 510K Ultrasonic Vibrating Micron Micro Mesh delivery device is able to efficiently deliver FDA approved pharmaceutical medical formulations with developments in the delivery of nano technology medication, Biologic and Biosimilar formulations , medical marijuana and nicotine.
Drug Compositions are delivered as a unit dose in hypertonic saline medical formulations in a single use disposable cartridge. Patent pending FDA approval for the combination use of the unit dose with the delivery device as a whole.
Device has digital display allowing the user to see how much medication has been taken, auto turnoff after 4 seconds, little chance of over use, over dose. Device is connected to the Internet of Things allowing the doctor to monitor patients use , time and amount of medication taken.
Ability to deliver drug formulations more efficiently than current methods. No needles, no tablets, no heating, no combustion ,no smell, no noise, no pain.
FDA approved production facilities which manufacture and assemble all the FDA 510K approved Pulmonary Drug delivery devices.
Device Alternatives for market segments such as Reduced Risk Products (RRP) delivering nicotine for the tobacco industry and delivery systems for the Nicotine Replacement Therapy Market.
Provides precise drug delivery to the lung without breath coordination in the (micro fine) nebulized form, suitable for all patient status.
Drug stability is not affected by the ultrasonic vibrating Micron Micro Mesh.
Mesh is made of platinum alloy which is non-toxic, durable and resistant to corrosion.
8000 holes per 15mm diameter mesh.
Small Volume, no noise, no heating required, no drug decomposition, effective, reliable and durable. No drug waste with visual assurance of drug delivery.
510 K certification, RoHs and REACH approval.
One of only two FDA approved micro mesh production facilities in the Far East.
Allows tenfold reduction in active ingredient which saves on cost and increases safety.
90% bio availability versus 26% for other inhaler devices.
10 second uptake of medication from the lungs to the brain
Easy to use, elegant, portable, affordable, easy dose loading reusable, light weight, low residue, no waste, unit dose and multi dose refills.